[09:50] Navigating FDA Challenges — Elizabeth reveals the timeline of Owlet’s regulatory journey: “We received a warning letter from the FDA saying, ‘You don’t have clearance as a medical device, but you’re essentially operating as one.’” She details how the company pivoted while working toward FDA clearance, ultimately achieving a de novo clearance, the first of its kind for over-the-counter infant monitoring technology.
[13:07] Product-First Marketing Philosophy — Elizabeth emphasizes her approach to marketing complex technology: “I challenge them to think, ‘The desired outcome is X. How we get there, there are a million pathways.’” She focuses on outcomes and benefits rather than technical features.
[19:13] Marketing as Strategic Function — Elizabeth describes how marketing is valued at Owlet: “Marketing has always been a valued perspective table, and I think that does come back to how it was founded and rooted in parenting problems to solve and how necessary marketing has been in explaining the value.”
[27:41] Community-Driven Growth — Elizabeth reveals the power of authentic community: “We have research that shows over 50% of Owlet purchasers first heard about it from a friend or family member, so we are heavily reliant on our community. I mean, that’s word-of-mouth that most brands would kill for, and it’s all positive and great.” She details their approach to nurturing parent communities through various channels and foundation programs.
